EDN2 and breast cancer: We observed a gradual increase in methylation across the luminal epitypes, ET2–ET5, of the CpG sites methylated in breast cancer, whereas only a subset of these CpG sites appeared to be methylated in the basal-like epitype ET7 (Fig. 1a).